Patient Advocacy Groups Urge Court to Halt Illegal Drug Imports Impacting U.S. Health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2026
0mins
Source: CNBC
- Patient Safety Risks: Patient advocacy groups have filed a court document urging the halt of third-party companies that illegally import drugs, arguing that this practice jeopardizes the health of U.S. patients, particularly those with HIV and hepatitis, and calling for judicial intervention to protect patient safety.
- Legal Action Background: The lawsuit stems from Gilead Sciences' complaint against an HIV patient who received medication with Turkish labeling, indicating that the drug entered the U.S. through an unsecured supply chain, violating FDA regulations.
- Market Impact Analysis: While alternative funding programs (AFPs) offer low-cost medications to small employers, their illegal nature and associated health risks could lead to treatment delays, increasing the burden on the healthcare system.
- Regulatory Challenges: Despite federal officials indicating ongoing criminal investigations into AFPs, patient groups argue that existing regulatory measures are insufficient to effectively curb these illegal import practices, urging the courts to take stronger action.
Analyst Views on CVS
Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is 96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 72.000
Low
91.00
Averages
96.71
High
105.00
Current: 72.000
Low
91.00
Averages
96.71
High
105.00
About CVS
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
